[Effect of atenolol on the excretion of catecholamines and their metabolites and dihydroxyphenylalanine (DOPA) in patients with essential hypertension].
D000328:Adult; D001262:Atenolol / Q000494:pharmacology* / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism / Q000652:urine*; D004295:Dihydroxyphenylalanine / Q000652:urine*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000652:urine; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000494:pharmacology*
D002395:Catecholamines; D011412:Propanolamines; D001262:Atenolol; D004295:Dihydroxyphenylalanine
Wpływ atenololu na wydalanie katecholamin i ich metabolitów oraz dwuhydroksyfenyloalaniny (DOPA) u chorych z nadciśnieniem pierwotnym.